{
  "name": "Palmitoylethanolamide (PEA)",
  "category": "supplement",
  "evidenceGrade": "B",
  "riskProfile": "low",
  "description": "Endogenous fatty acid amide that acts on the endocannabinoid system without binding CB1/CB2 receptors. Anti-inflammatory and analgesic via PPAR-α activation and mast cell downregulation. Nobel laureate Rita Levi-Montalcini studied its neuroprotective properties.",
  "mechanisms": [
    "PPAR-α agonism",
    "Mast cell downregulation",
    "Endocannabinoid tone modulation (entourage effect)",
    "Neuroinflammation reduction"
  ],
  "dosage": {
    "standard": "300-600mg 2x/day",
    "range": "300-1200mg/day",
    "notes": "Micronized or ultra-micronized form for better absorption (OptiPEA). Take with or without food. Onset of pain relief: 2-4 weeks. Studied since 1950s."
  },
  "keyFindings": [
    "Reduced chronic pain in multiple RCTs (NNT comparable to pregabalin)",
    "Anti-inflammatory without GI side effects of NSAIDs",
    "Nobel laureate Levi-Montalcini studied its mast cell and neuroimmune effects"
  ],
  "interactions": [
    "None significant known"
  ],
  "sideEffects": [
    "Minimal — excellent safety profile",
    "Mild GI discomfort (rare)"
  ],
  "contraindications": [
    "None established"
  ],
  "tags": [
    "supplement",
    "anti-inflammatory",
    "pain",
    "endocannabinoid",
    "neuroprotective",
    "safe"
  ],
  "estimatedMonthlyCost": {
    "low": 20,
    "mid": 35,
    "high": 60,
    "currency": "USD"
  },
  "id": "prod-palmitoylethanolamide-pea",
  "sources": [],
  "suppliers": [],
  "communityReports": [],
  "expertOpinions": [],
  "lastUpdated": "2026-02-04T14:50:14.852Z",
  "createdAt": "2026-02-04T14:50:14.852Z"
}